| Year |
Citation |
Score |
| 2023 |
Wang A, Zhou D, Krawczyk E, Li T, Simic V, Lu J, Liu X, Schlegel R, Yuan H. Overexpression of the Telomerase Holoenzyme Induces EMT and Tumorigenesis of HPV-Immortalized Keratinocytes. Journal of Medical Virology. PMID 36929719 DOI: 10.1002/jmv.28681 |
0.477 |
|
| 2022 |
Sudarshan SR, Schlegel R, Liu X. Two conserved amino acids differentiate the biology of high-risk and low-risk HPV E5 proteins. Journal of Medical Virology. PMID 35509176 DOI: 10.1002/jmv.27829 |
0.814 |
|
| 2022 |
Miller J, Dakic A, Spurgeon M, Saenz F, Kallakury B, Zhao B, Zhang J, Zhu J, Ma Q, Xu Y, Lambert P, Schlegel R, Riegel AT, Liu X. AIB1 Is A Novel Target of the High-Risk HPV E6 protein and A Biomarker of Cervical Cancer Progression. Journal of Medical Virology. PMID 35437795 DOI: 10.1002/jmv.27795 |
0.483 |
|
| 2019 |
Palechor-Ceron N, Krawczyk E, Dakic A, Simic V, Yuan H, Blancato J, Wang W, Hubbard F, Zheng YL, Dan H, Strome S, Cullen K, Davidson B, Deeken JF, Choudhury S, ... ... Schlegel R, et al. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks. Cells. 8. PMID 31717887 DOI: 10.3390/Cells8111327 |
0.322 |
|
| 2019 |
Krawczyk E, Hong SH, Galli S, Trinh E, Wietlisbach L, Misiukiewicz SF, Tilan JU, Chen YS, Schlegel R, Kitlinska J. Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 31409888 DOI: 10.1038/S41374-019-0297-7 |
0.328 |
|
| 2019 |
Allen CT, Lee S, Norberg SM, Kovalovsky D, Ye H, Clavijo PE, Hu-Lieskovan S, Schlegel R, Schlom J, Strauss J, Gulley JL, Trepel J, Hinrichs CS. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis. Journal For Immunotherapy of Cancer. 7: 119. PMID 31053174 DOI: 10.1186/S40425-019-0603-3 |
0.311 |
|
| 2018 |
Mondal AM, Zhou H, Horikawa I, Suprynowicz FA, Li G, Dakic A, Rosenthal B, Ye L, Harris CC, Schlegel R, Liu X. Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells. Cell Death & Disease. 9: 750. PMID 29970881 DOI: 10.1038/S41419-018-0767-7 |
0.356 |
|
| 2018 |
Correa BRS, Hu J, Penalva LOF, Schlegel R, Rimm DL, Galante PAF, Agarwal S. Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity. Scientific Reports. 8: 4097. PMID 29511269 DOI: 10.1038/S41598-018-22427-1 |
0.324 |
|
| 2018 |
Casciano JC, Cohen-Nowak A, Voorde JV, Zhang Q, Chalmers S, Sandison M, Hedley A, McBryan T, Beer T, Tang H, Speicher DW, Adams P, Liu X, Schlegel R, McCarron J, et al. Abstract 1441: MYC expression promotes lipid metabolism and metabolic plasticity in human mammary epithelial cell Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-1441 |
0.32 |
|
| 2017 |
Zhang Y, Dakic A, Chen R, Dai Y, Schlegel R, Liu X. Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation. Oncotarget. 8: 96323-96339. PMID 29221209 DOI: 10.18632/Oncotarget.22036 |
0.565 |
|
| 2017 |
Suprynowicz FA, Kamonjoh CM, Krawczyk E, Agarwal S, Wellstein A, Agboke FA, Choudhury S, Liu X, Schlegel R. Conditional cell reprogramming involves non-canonical β-catenin activation and mTOR-mediated inactivation of Akt. Plos One. 12: e0180897. PMID 28700668 DOI: 10.1371/Journal.Pone.0180897 |
0.317 |
|
| 2017 |
Yuan H, Krawczyk E, Blancato J, Albanese C, Zhou D, Wang N, Paul S, Alkhilaiwi F, Palechor-Ceron N, Dakic A, Fang S, Choudhary S, Hou TW, Zheng YL, Haddad BR, ... ... Schlegel R, et al. HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes. Scientific Reports. 7: 45617. PMID 28378747 DOI: 10.1038/Srep45617 |
0.512 |
|
| 2017 |
Liu X, Krawczyk E, Suprynowicz FA, Palechor-Ceron N, Yuan H, Dakic A, Simic V, Zheng YL, Sripadhan P, Chen C, Lu J, Hou TW, Choudhury S, Kallakury B, Tang D, ... ... Schlegel R, et al. Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens. Nature Protocols. 12: 439-451. PMID 28125105 DOI: 10.1038/Nprot.2016.174 |
0.339 |
|
| 2017 |
Dakic A, Palechor-Ceron N, Krawczyk E, Yuan H, Suprynowicz F, Agarwal S, Schlegel R, Simic V, Sripadhan P, Chen C, Lu J, Hou T, Choudhury S, Liu X. Abstract 5777: Translation of HPV mediated immortalization to cancer precision medicine Cancer Research. 77: 5777-5777. DOI: 10.1158/1538-7445.Am2017-5777 |
0.42 |
|
| 2016 |
Timofeeva OA, Palechor-Ceron N, Li G, Yuan H, Krawczyk E, Zhong X, Liu G, Upadhyay G, Dakic A, Yu S, Fang S, Choudhury S, Zhang X, Ju A, Lee MS, ... ... Schlegel R, et al. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer. Oncotarget. PMID 28009986 DOI: 10.18632/Oncotarget.13937 |
0.333 |
|
| 2016 |
Gentzsch M, Boyles SE, Cheluvaraju C, Chaudhry IG, Quinney NL, Cho C, Dang H, Liu X, Schlegel R, Randell SH. Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. PMID 27983869 DOI: 10.1165/Rcmb.2016-0276Ma |
0.311 |
|
| 2016 |
Tisza MJ, Yuan H, Schlegel R, Buck CB. Genomic Sequence of Canine Papillomavirus 19. Genome Announcements. 4. PMID 27932663 DOI: 10.1128/Genomea.01380-16 |
0.333 |
|
| 2016 |
Dakic A, DiVito K, Fang S, Suprynowicz F, Gaur A, Li X, Palechor-Ceron N, Simic V, Choudhury S, Yu S, Simbulan-Rosenthal CM, Rosenthal D, Schlegel R, Liu X. ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes. Oncotarget. PMID 27556514 DOI: 10.18632/Oncotarget.11458 |
0.471 |
|
| 2016 |
Chen C, Choudhury S, Wilkins D, Glasgow E, Schlegel R, Agarwal S. Abstract PR06: Conditional reprogramming is successful in generating patient-derived stable cell cultures from rare aggressive tumors Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-Pr06 |
0.341 |
|
| 2016 |
Schlegel R. Abstract IA26: Conditionally Reprogrammed Cells (CRCs): A simple, two-component cell system for basic and clinical cancer research Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-Ia26 |
0.339 |
|
| 2016 |
Liu X, Krawczyk E, Timofeeva O, Palechor-Ceron N, Dakic A, Simic V, Kallakury B, Dritschilo A, Schlegel R. Abstract 4256: Functional analysis for cancer precision medicine using patient-derived 2D and 3D cell models Cancer Research. 76: 4256-4256. DOI: 10.1158/1538-7445.Am2016-4256 |
0.316 |
|
| 2016 |
Meyer R, McNeil NE, Krawczyk E, Rosenberg DW, Zhang Z, Schlegel R, Habermann JK, Ried T. Abstract 2402: The impact of genomic heterogeneity in colorectal carcinoma on therapy response - a study on monoclonal primary colon cultures Cancer Research. 76: 2402-2402. DOI: 10.1158/1538-7445.Am2016-2402 |
0.334 |
|
| 2015 |
Luff J, Mader M, Britton M, Fass J, Rowland P, Orr C, Schlegel R, Yuan H. Complete genome sequence of canine papillomavirus type 16. Genome Announcements. 3. PMID 25953189 DOI: 10.1128/Genomea.00404-15 |
0.319 |
|
| 2015 |
Dakic A, Fang S, Choudhury S, Palechor-Ceron N, Yu S, Schlegel R, Liu X. Abstract A30: In vitro transformation of human primary epithelial cells by Myc Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-A30 |
0.521 |
|
| 2015 |
Dakic A, Divito K, Fang S, Palechor-Ceron N, Simic V, Choudhury S, Yu S, Simbulan-Rosenthal CM, Rosenthal D, Schlegel R, Liu X. Abstract 5145: Y-27632 inhibits Myc-induced apoptosis and cooperates with Myc to immortalize human keratinocytes Cancer Research. 75: 5145-5145. DOI: 10.1158/1538-7445.Am2015-5145 |
0.489 |
|
| 2015 |
Chen C, Choudhury S, Liu X, Schlegel R, Agarwal S. Abstract 5138: New technique generates cell cultures from rare adenoid cystic carcinomas of the salivary gland Cancer Research. 75: 5138-5138. DOI: 10.1158/1538-7445.Am2015-5138 |
0.337 |
|
| 2014 |
Ringer L, Sirajuddin P, Tricoli L, Waye S, Choudhry MU, Parasido E, Sivakumar A, Heckler M, Naeem A, Abdelgawad I, Liu X, Feldman AS, Lee RJ, Wu CL, Yenugonda V, ... ... Schlegel R, et al. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells. Oncotarget. 5: 10678-91. PMID 25296977 DOI: 10.18632/Oncotarget.2528 |
0.323 |
|
| 2014 |
Saenz FR, Ory V, AlOtaiby M, Rosenfield S, Furlong M, Cavalli LR, Johnson MD, Liu X, Schlegel R, Wellstein A, Riegel AT. Conditionally reprogrammed normal and transformed mouse mammary epithelial cells display a progenitor-cell-like phenotype. Plos One. 9: e97666. PMID 24831228 DOI: 10.1371/Journal.Pone.0097666 |
0.321 |
|
| 2014 |
Pollock CB, McDonough S, Wang VS, Lee H, Ringer L, Li X, Prandi C, Lee RJ, Feldman AS, Koltai H, Kapulnik Y, Rodriguez OC, Schlegel R, Albanese C, Yarden RI. Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells. Oncotarget. 5: 1683-98. PMID 24742967 DOI: 10.18632/Oncotarget.1849 |
0.349 |
|
| 2014 |
Zheng YL, Zhang F, Sun B, Du J, Sun C, Yuan J, Wang Y, Tao L, Kota K, Liu X, Schlegel R, Yang Q. Telomerase enzymatic component hTERT shortens long telomeres in human cells. Cell Cycle (Georgetown, Tex.). 13: 1765-76. PMID 24721976 DOI: 10.4161/Cc.28705 |
0.301 |
|
| 2014 |
Bove PF, Dang H, Cheluvaraju C, Jones LC, Liu X, O'Neal WK, Randell SH, Schlegel R, Boucher RC. Breaking the in vitro alveolar type II cell proliferation barrier while retaining ion transport properties. American Journal of Respiratory Cell and Molecular Biology. 50: 767-76. PMID 24191670 DOI: 10.1165/Rcmb.2013-0071Oc |
0.356 |
|
| 2014 |
Liu X, Krawczyk E, Palechor-Ceron N, Wang W, Yuan H, Dakic A, Simic V, Kullakury B, Furth P, Schlegel R. Abstract 2972: Conditionally reprogrammed cells (CRCs): A new model for cancer research and personalized medicine Cancer Research. 74: 2972-2972. DOI: 10.1158/1538-7445.Am2014-2972 |
0.327 |
|
| 2013 |
Palechor-Ceron N, Suprynowicz FA, Upadhyay G, Dakic A, Minas T, Simic V, Johnson M, Albanese C, Schlegel R, Liu X. Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells. The American Journal of Pathology. 183: 1862-70. PMID 24096078 DOI: 10.1016/J.Ajpath.2013.08.009 |
0.343 |
|
| 2013 |
Yuan H, Zhou D, Wang J, Schlegel R. Divergent human papillomavirus associated with recurrent respiratory papillomatosis with lung involvement. Genome Announcements. 1. PMID 23846273 DOI: 10.1128/Genomea.00474-13 |
0.469 |
|
| 2013 |
Miller J, Dakic A, Chen R, Palechor-Ceron N, Dai Y, Kallakury B, Schlegel R, Liu X. HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes. Plos Pathogens. 9: e1003284. PMID 23592995 DOI: 10.1371/Journal.Ppat.1003284 |
0.577 |
|
| 2013 |
Luff JA, Yuan H, Suter MM, Müller EJ, Schlegel R, Moore PF. Canine keratinocytes upregulate type I interferons and proinflammatory cytokines in response to poly(dA:dT) but not to canine papillomavirus. Veterinary Immunology and Immunopathology. 153: 177-86. PMID 23557936 DOI: 10.1016/J.Vetimm.2013.02.001 |
0.35 |
|
| 2013 |
Agarwal S, Hu J, Stanton K, Schalper K, Kluger Y, Zarrella E, Liu X, Schlegel R, Rimm DL. Abstract 1569: Next generation cell line models: conditionally reprogrammed cells. Cancer Research. 73: 1569-1569. DOI: 10.1158/1538-7445.Am2013-1569 |
0.332 |
|
| 2013 |
Schlegel R, Pelacor-Ceron N, Suprynowicz F, Albanese C, Yuan H, Liu X. Abstract CN03-02: Conditionally reprogrammed cells for personalized medicine. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-Cn03-02 |
0.407 |
|
| 2012 |
Suprynowicz FA, Upadhyay G, Krawczyk E, Kramer SC, Hebert JD, Liu X, Yuan H, Cheluvaraju C, Clapp PW, Boucher RC, Kamonjoh CM, Randell SH, Schlegel R. Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 20035-40. PMID 23169653 DOI: 10.1073/Pnas.1213241109 |
0.334 |
|
| 2012 |
Yuan H, Myers S, Wang J, Zhou D, Woo JA, Kallakury B, Ju A, Bazylewicz M, Carter YM, Albanese C, Grant N, Shad A, Dritschilo A, Liu X, Schlegel R. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. The New England Journal of Medicine. 367: 1220-7. PMID 23013073 DOI: 10.1056/Nejmoa1203055 |
0.351 |
|
| 2012 |
Sahab Z, Sudarshan SR, Liu X, Zhang Y, Kirilyuk A, Kamonjoh CM, Simic V, Dai Y, Byers SW, Doorbar J, Suprynowicz FA, Schlegel R. Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry. Journal of Virology. 86: 9465-73. PMID 22740411 DOI: 10.1128/Jvi.01032-12 |
0.826 |
|
| 2012 |
Liu X, Ory V, Chapman S, Yuan H, Albanese C, Kallakury B, Timofeeva OA, Nealon C, Dakic A, Simic V, Haddad BR, Rhim JS, Dritschilo A, Riegel A, McBride A, ... Schlegel R, et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. The American Journal of Pathology. 180: 599-607. PMID 22189618 DOI: 10.1016/J.Ajpath.2011.10.036 |
0.354 |
|
| 2012 |
Bonilla-Delgado J, Bulut G, Liu X, Cortés-Malagón EM, Schlegel R, Flores-Maldonado C, Contreras RG, Chung SH, Lambert PF, Uren A, Gariglio P. The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo. Molecular Cancer Research : McR. 10: 250-8. PMID 22160870 DOI: 10.1158/1541-7786.Mcr-11-0287 |
0.508 |
|
| 2012 |
Woo JA, Yuan H, Liu X, Schlegel R, Grant N, Harley E, Myers S. Pulmonary Papillomatosis: HPV11 Mutation and Vorinostat Therapy Otolaryngology-Head and Neck Surgery. 147. DOI: 10.1177/0194599812451426A221 |
0.403 |
|
| 2011 |
Bulut G, Fallen S, Beauchamp EM, Drebing LE, Sun J, Berry DL, Kallakury B, Crum CP, Toretsky JA, Schlegel R, Üren A. Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic mice. Plos One. 6: e27243. PMID 22087269 DOI: 10.1371/Journal.Pone.0027243 |
0.49 |
|
| 2011 |
Ringer L, Sirajuddin P, Heckler M, Ghosh A, Suprynowicz F, Yenugonda VM, Brown ML, Toretsky JA, Uren A, Lee Y, MacDonald TJ, Rodriguez O, Glazer RI, Schlegel R, Albanese C. VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. Cancer Biology & Therapy. 12: 818-26. PMID 21885916 DOI: 10.4161/Cbt.12.9.17682 |
0.321 |
|
| 2011 |
Krawczyk E, Suprynowicz FA, Hebert JD, Kamonjoh CM, Schlegel R. The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region. Journal of Virology. 85: 10968-75. PMID 21849434 DOI: 10.1128/Jvi.00706-11 |
0.586 |
|
| 2011 |
Bulut G, Fallen S, Beauchamp EM, Drebing LE, Sun J, Berry DL, Kallakury B, Crum CP, Toretsky JA, Schlegel R, Üren A. Abstract 4328: Beta-catenin accelerates human papillomavirus type16 -E7 mediated cervical carcinogenesis in transgenic mice Cancer Research. 71: 4328-4328. DOI: 10.1158/1538-7445.Am2011-4328 |
0.49 |
|
| 2010 |
Wang J, Zhou D, Prabhu A, Schlegel R, Yuan H. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein. Plos Pathogens. 6: e1001089. PMID 20824099 DOI: 10.1371/Journal.Ppat.1001089 |
0.579 |
|
| 2010 |
Sudarshan SR, Schlegel R, Liu X. The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes. Biochemical and Biophysical Research Communications. 399: 617-22. PMID 20688044 DOI: 10.1016/J.Bbrc.2010.07.125 |
0.828 |
|
| 2010 |
Suprynowicz FA, Krawczyk E, Hebert JD, Sudarshan SR, Simic V, Kamonjoh CM, Schlegel R. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. Journal of Virology. 84: 10619-29. PMID 20686024 DOI: 10.1128/Jvi.00831-10 |
0.791 |
|
| 2010 |
Chapman S, Liu X, Meyers C, Schlegel R, McBride AA. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. The Journal of Clinical Investigation. 120: 2619-26. PMID 20516646 DOI: 10.1172/Jci42297 |
0.318 |
|
| 2010 |
Peran I, Riegel A, Dai Y, Schlegel R, Liu X. Is HPV-18 present in human breast cancer cell lines? British Journal of Cancer. 102: 1549-1550. PMID 20407441 DOI: 10.1038/Sj.Bjc.6605671 |
0.463 |
|
| 2010 |
Krawczyk E, Suprynowicz FA, Sudarshan SR, Schlegel R. Membrane orientation of the human papillomavirus type 16 E5 oncoprotein. Journal of Virology. 84: 1696-703. PMID 19955310 DOI: 10.1128/Jvi.01968-09 |
0.795 |
|
| 2010 |
Sudarshan SR, Liu X, Schlegel R. Abstract LB-112: The human papillomavirus type 16 E5 protein represses X-box binding protein 1 and cyclooxygenase-2 stress signaling in keratinocytes Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-112 |
0.833 |
|
| 2009 |
Liu X, Dakic A, Zhang Y, Dai Y, Chen R, Schlegel R. HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proceedings of the National Academy of Sciences of the United States of America. 106: 18780-5. PMID 19843693 DOI: 10.1073/Pnas.0906357106 |
0.571 |
|
| 2009 |
Condjella R, Liu X, Suprynowicz F, Yuan H, Sudarshan S, Dai Y, Schlegel R. The canine papillomavirus e5 protein signals from the endoplasmic reticulum. Journal of Virology. 83: 12833-41. PMID 19812158 DOI: 10.1128/Jvi.01003-09 |
0.771 |
|
| 2009 |
Thibodeaux CA, Liu X, Disbrow GL, Zhang Y, Rone JD, Haddad BR, Schlegel R. Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant. Breast Cancer Research and Treatment. 116: 281-94. PMID 18642118 DOI: 10.1007/S10549-008-0127-X |
0.395 |
|
| 2008 |
Liu X, Dakic A, Chen R, Disbrow GL, Zhang Y, Dai Y, Schlegel R. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc. Journal of Virology. 82: 11568-76. PMID 18818322 DOI: 10.1128/Jvi.01318-08 |
0.6 |
|
| 2008 |
Krawczyk E, Suprynowicz FA, Liu X, Dai Y, Hartmann DP, Hanover J, Schlegel R. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. The American Journal of Pathology. 173: 682-8. PMID 18688031 DOI: 10.2353/Ajpath.2008.080280 |
0.606 |
|
| 2008 |
Krawczyk E, Hanover JA, Schlegel R, Suprynowicz FA. Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. Biochemical and Biophysical Research Communications. 371: 684-8. PMID 18455505 DOI: 10.1016/J.Bbrc.2008.04.122 |
0.573 |
|
| 2008 |
Liu X, Roberts J, Dakic A, Zhang Y, Schlegel R. HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function. Virology. 375: 611-23. PMID 18367227 DOI: 10.1016/J.Virol.2008.02.025 |
0.597 |
|
| 2008 |
Suprynowicz FA, Disbrow GL, Krawczyk E, Simic V, Lantzky K, Schlegel R. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells. Oncogene. 27: 1071-8. PMID 17704805 DOI: 10.1038/Sj.Onc.1210725 |
0.584 |
|
| 2007 |
Liu X, Disbrow GL, Yuan H, Tomaic V, Schlegel R. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes. Journal of Virology. 81: 12689-95. PMID 17804506 DOI: 10.1128/Jvi.00669-07 |
0.561 |
|
| 2007 |
Yuan H, Ghim S, Newsome J, Apolinario T, Olcese V, Martin M, Delius H, Felsburg P, Jenson B, Schlegel R. An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus. Virology. 359: 28-36. PMID 17034826 DOI: 10.1016/J.Virol.2006.08.029 |
0.449 |
|
| 2006 |
Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL, Weissman AM, Schlegel R, Wellstein A, Riegel AT. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Research. 66: 8680-6. PMID 16951183 DOI: 10.1158/0008-5472.Can-06-0557 |
0.356 |
|
| 2006 |
Saha T, Vardhini D, Tang Y, Katuri V, Jogunoori W, Volpe EA, Haines D, Sidawy A, Zhou X, Gallicano I, Schlegel R, Mishra B, Mishra L. RING finger-dependent ubiquitination by PRAJA is dependent on TGF-β and potentially defines the functional status of the tumor suppressor ELF Oncogene. 25: 693-705. PMID 16247473 DOI: 10.1038/Sj.Onc.1209123 |
0.375 |
|
| 2005 |
Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R. Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Research. 65: 10854-61. PMID 16322232 DOI: 10.1158/0008-5472.Can-05-1216 |
0.483 |
|
| 2005 |
Genther Williams SM, Disbrow GL, Schlegel R, Lee D, Threadgill DW, Lambert PF. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Research. 65: 6534-42. PMID 16061632 DOI: 10.1158/0008-5472.Can-05-0083 |
0.509 |
|
| 2005 |
Uren A, Fallen S, Yuan H, Usubütün A, Küçükali T, Schlegel R, Toretsky JA. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Research. 65: 6199-206. PMID 16024621 DOI: 10.1158/0008-5472.Can-05-0455 |
0.449 |
|
| 2005 |
Zhang Y, Fan S, Meng Q, Ma Y, Katiyar P, Schlegel R, Rosen EM. BRCA1 interaction with human papillomavirus oncoproteins. The Journal of Biological Chemistry. 280: 33165-77. PMID 15983032 DOI: 10.1074/Jbc.M505124200 |
0.487 |
|
| 2005 |
Disbrow GL, Hanover JA, Schlegel R. Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. Journal of Virology. 79: 5839-46. PMID 15827198 DOI: 10.1128/Jvi.79.9.5839-5846.2005 |
0.501 |
|
| 2005 |
Berg M, Difatta J, Hoiczyk E, Schlegel R, Ketner G. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit. Proceedings of the National Academy of Sciences of the United States of America. 102: 4590-5. PMID 15767581 DOI: 10.1073/Pnas.0500933102 |
0.354 |
|
| 2005 |
Magal SS, Jackman A, Ish-Shalom S, Botzer LE, Gonen P, Schlegel R, Sherman L. Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. The Journal of General Virology. 86: 611-21. PMID 15722521 DOI: 10.1099/Vir.0.80453-0 |
0.535 |
|
| 2005 |
Suprynowicz FA, Disbrow GL, Simic V, Schlegel R. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? Virology. 332: 102-13. PMID 15661144 DOI: 10.1016/J.Virol.2004.11.011 |
0.604 |
|
| 2005 |
Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, Tomaic V, Kelley ML, Baker CC, Huibregtse J, Schlegel R. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. The Journal of Biological Chemistry. 280: 10807-16. PMID 15655249 DOI: 10.1074/Jbc.M410343200 |
0.503 |
|
| 2004 |
Olcese VA, Chen Y, Schlegel R, Yuan H. Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope. Bmc Microbiology. 4: 29. PMID 15260888 DOI: 10.1186/1471-2180-4-29 |
0.393 |
|
| 2004 |
Baege AC, Disbrow GL, Schlegel R. IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis. Journal of Virology. 78: 5720-7. PMID 15140969 DOI: 10.1128/Jvi.78.11.5720-5727.2004 |
0.449 |
|
| 2003 |
Disbrow GL, Sunitha I, Baker CC, Hanover J, Schlegel R. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology. 311: 105-14. PMID 12832208 DOI: 10.1016/S0042-6822(03)00129-6 |
0.599 |
|
| 2003 |
Veldman T, Liu X, Yuan H, Schlegel R. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proceedings of the National Academy of Sciences of the United States of America. 100: 8211-6. PMID 12821782 DOI: 10.1073/Pnas.1435900100 |
0.538 |
|
| 2003 |
Wlazlo AP, Sparkowski JJ, Jenson AB, Schlegel R. Expression of the bovine papillomavirus type 1 E5B gene reveals a protein-protein interaction of the E5A and E5B gene products. Virology. 307: 396-405. PMID 12667807 DOI: 10.1016/S0042-6822(02)00090-9 |
0.385 |
|
| 2002 |
Yuan H, Veldman T, Rundell K, Schlegel R. Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. Journal of Virology. 76: 10685-91. PMID 12368310 DOI: 10.1128/Jvi.76.21.10685-10691.2002 |
0.376 |
|
| 2002 |
Berger AJ, Baege A, Guillemette T, Deeds J, Meyer R, Disbrow G, Schlegel R, Schlegel R. Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. The American Journal of Pathology. 161: 603-10. PMID 12163384 DOI: 10.1016/S0002-9440(10)64215-0 |
0.58 |
|
| 2002 |
Simbulan-Rosenthal CM, Velena A, Veldman T, Schlegel R, Rosenthal DS. HPV-16 E6/7 immortalization sensitizes human keratinocytes to ultraviolet B by altering the pathway from caspase-8 to caspase-9-dependent apoptosis. The Journal of Biological Chemistry. 277: 24709-16. PMID 11976323 DOI: 10.1074/Jbc.M200281200 |
0.527 |
|
| 2002 |
Baege AC, Berger A, Schlegel R, Veldman T, Schlegel R. Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. The American Journal of Pathology. 160: 1251-7. PMID 11943710 DOI: 10.1016/S0002-9440(10)62552-7 |
0.574 |
|
| 2002 |
Suprynowicz FA, Baege A, Sunitha I, Schlegel R. c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation. Oncogene. 21: 1695-706. PMID 11896601 DOI: 10.1038/Sj.Onc.1205223 |
0.427 |
|
| 2002 |
Sherman L, Itzhaki H, Jackman A, Chen JJ, Koval D, Schlegel R. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. Virology. 292: 309-20. PMID 11878933 DOI: 10.1006/Viro.2001.1263 |
0.452 |
|
| 2001 |
Carr EA, Théon AP, Madewell BR, Hitchcock ME, Schlegel R, Schiller JT. Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses American Journal of Veterinary Research. 62: 1212-1217. PMID 11497440 DOI: 10.2460/Ajvr.2001.62.1212 |
0.49 |
|
| 2001 |
Yuan H, Estes PA, Chen Y, Newsome J, Olcese VA, Garcea RL, Schlegel R. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. Journal of Virology. 75: 7848-53. PMID 11483728 DOI: 10.1128/Jvi.75.17.7848-7853.2001 |
0.335 |
|
| 2001 |
Veldman T, Horikawa I, Barrett JC, Schlegel R. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. Journal of Virology. 75: 4467-4472. PMID 11287602 DOI: 10.1128/Jvi.75.9.4467-4472.2001 |
0.559 |
|
| 2000 |
Suprynowicz FA, Sparkowski J, Baege A, Schlegel R. E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation. The Journal of Biological Chemistry. 275: 5111-9. PMID 10671555 DOI: 10.1074/Jbc.275.7.5111 |
0.449 |
|
| 2000 |
Schapiro F, Sparkowski J, Adduci A, Suprynowicz F, Schlegel R, Grinstein S. Golgi alkalinization by the papillomavirus E5 oncoprotein. The Journal of Cell Biology. 148: 305-15. PMID 10648563 DOI: 10.1083/Jcb.148.2.305 |
0.43 |
|
| 1999 |
Alfandari J, Shnitman Magal S, Jackman A, Schlegel R, Gonen P, Sherman L. HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology. 257: 383-96. PMID 10329549 DOI: 10.1006/Viro.1999.9675 |
0.533 |
|
| 1999 |
Adduci AJ, Schlegel R. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces Journal of Biological Chemistry. 274: 10249-10258. PMID 10187811 DOI: 10.1074/Jbc.274.15.10249 |
0.432 |
|
| 1998 |
Saito T, Schlegel R, Andresson T, Yuge L, Yamamoto M, Yamasaki H. Induction of cell transformation by mutated 16K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells. Oncogene. 17: 1673-1680. PMID 9796696 DOI: 10.1038/Sj.Onc.1202092 |
0.35 |
|
| 1998 |
Stöppler H, Stöppler MC, Johnson E, Simbulan-Rosenthal CM, Smulson ME, Iyer S, Rosenthal DS, Schlegel R. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene. 17: 1207-14. PMID 9771963 DOI: 10.1038/Sj.Onc.1202053 |
0.55 |
|
| 1998 |
Chen Y, Ghim SJ, Jenson AB, Schlegel R. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes. The Journal of General Virology. 79: 2137-46. PMID 9747722 DOI: 10.1099/0022-1317-79-9-2137 |
0.337 |
|
| 1998 |
Pei XF, Sherman L, Sun YH, Schlegel R. HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium. Carcinogenesis. 19: 1481-6. PMID 9744546 DOI: 10.1093/Carcin/19.8.1481 |
0.596 |
|
| 1998 |
Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes Oncogene. 16: 2711-2721. PMID 9652737 DOI: 10.1038/Sj.Onc.1201798 |
0.485 |
|
| 1998 |
Magal SS, Jackman A, Pei XF, Schlegel R, Sherman L. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins International Journal of Cancer. 75: 96-104. PMID 9426696 DOI: 10.1002/(Sici)1097-0215(19980105)75:1<96::Aid-Ijc15>3.0.Co;2-B |
0.552 |
|
| 1997 |
Sherman L, Jackman A, Itzhaki H, Stöppler MC, Koval D, Schlegel R. Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation. Virology. 237: 296-306. PMID 9356341 DOI: 10.1006/Viro.1997.8778 |
0.499 |
|
| 1997 |
Stöppler H, Hartmann DP, Sherman L, Schlegel R. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. The Journal of Biological Chemistry. 272: 13332-7. PMID 9148955 DOI: 10.1074/Jbc.272.20.13332 |
0.613 |
|
| 1996 |
Stöppler MC, Straight SW, Tsao G, Schlegel R, McCance DJ. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA Virology. 223: 251-254. PMID 8806560 DOI: 10.1006/Viro.1996.0475 |
0.569 |
|
| 1996 |
Stöppler MC, Ching K, Stöppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. Journal of Virology. 70: 6987-6993. PMID 8794343 DOI: 10.1128/Jvi.70.10.6987-6993.1996 |
0.542 |
|
| 1996 |
Sparkowski J, Mense M, Anders J, Schlegel R. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. Journal of Virology. 70: 2420-30. PMID 8642670 DOI: 10.1128/Jvi.70.4.2420-2430.1996 |
0.479 |
|
| 1996 |
Sherman L, Schlegel R. Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. Journal of Virology. 70: 3269-79. PMID 8627810 DOI: 10.1128/JVI.70.5.3269-3279.1996 |
0.492 |
|
| 1996 |
Stöppler H, Stöppler MC, Adduci A, Koval D, Schlegel R. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability. Virology. 217: 542-53. PMID 8610446 DOI: 10.1006/Viro.1996.0149 |
0.587 |
|
| 1995 |
Suzich JA, Ghim SJ, Palmer-Hill FJ, White WI, Tamura JK, Bell JA, Newsome JA, Jenson AB, Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proceedings of the National Academy of Sciences of the United States of America. 92: 11553-7. PMID 8524802 DOI: 10.1073/Pnas.92.25.11553 |
0.321 |
|
| 1995 |
Andresson T, Sparkowski J, Goldstein DJ, Schlegel R. Vacuolar H+-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein Journal of Biological Chemistry. 270: 6830-6837. PMID 7896830 DOI: 10.1074/Jbc.270.12.6830 |
0.424 |
|
| 1995 |
Staebler A, Pierce JH, Brazinski S, Heidaran MA, Li W, Schlegel R, Goldstein DJ. Mutational analysis of the β-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein Journal of Virology. 69: 6507-6517. PMID 7666552 DOI: 10.1128/JVI.69.10.6507-6517.1995 |
0.317 |
|
| 1995 |
Hines JF, Ghim S, Schlegel R, Jenson AB. Prospects for a vaccine against human papillomavirus. Obstetrics and Gynecology. 86: 860-6. PMID 7566866 DOI: 10.1016/0029-7844(95)00248-P |
0.424 |
|
| 1995 |
Sherman L, Schlegel R. The E6 gene of HPV 16 is sufficient for colony formation in primary human keratinocytes Journal of Cancer Research and Clinical Oncology. 121: S24-S24. DOI: 10.1007/BF02559849 |
0.423 |
|
| 1995 |
Sparkowski J, Anders J, Schlegel R. E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells. The Embo Journal. 14: 3055-3063. DOI: 10.1002/J.1460-2075.1995.Tb07308.X |
0.502 |
|
| 1994 |
Sparkowski J, Anders J, Schlegel R. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. Journal of Virology. 68: 6120-6123. PMID 8057494 DOI: 10.1128/Jvi.68.9.6120-6123.1994 |
0.475 |
|
| 1994 |
Pei XF, Qin NG, Meck JM, Schlegel R. Keratinocytes immortalized by human papillomavirus-18 exhibit alterations dependent upon host genetic background and complexity of viral genes transfected. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 62: 43-52. PMID 8031475 DOI: 10.1159/000163876 |
0.49 |
|
| 1994 |
Conrad M, Goldstein D, Andresson T, Schlegel R. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. Virology. 200: 796-800. PMID 7909971 DOI: 10.1006/Viro.1994.1244 |
0.515 |
|
| 1994 |
Christensen ND, Kirnbauer R, Schiller JT, Ghim SJ, Schlegel R, Jenson AB, Kreider JW. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology. 205: 329-35. PMID 7526536 DOI: 10.1006/Viro.1994.1649 |
0.425 |
|
| 1994 |
Hines JF, Ghim SJ, Christensen ND, Kreider JW, Barnes WA, Schlegel R, Jenson AB. Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination. Gynecologic Oncology. 55: 13-20. PMID 7525426 DOI: 10.1006/Gyno.1994.1239 |
0.451 |
|
| 1993 |
Pei XF, Meck JM, Greenhalgh D, Schlegel R. Cotransfection of HPV-18 and v-fos DNA induces tumorigenicity of primary human keratinocytes. Virology. 196: 855-60. PMID 8396813 DOI: 10.1006/Viro.1993.1546 |
0.496 |
|
| 1993 |
Cohen BD, Goldstein DJ, Rutledge L, Vass WC, Lowy DR, Schlegel R, Schiller JT. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. Journal of Virology. 67: 5303-11. PMID 8394451 DOI: 10.1128/Jvi.67.9.5303-5311.1993 |
0.355 |
|
| 1993 |
Franchini G, Mulloy JC, Koralnik IJ, Monico AL, Sparkowski JJ, Andresson T, Goldstein DJ, Schlegel R. The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase Journal of Virology. 67: 7701-7704. PMID 8230493 |
0.427 |
|
| 1993 |
Conrad M, Bubb VJ, Schlegel R. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. Journal of Virology. 67: 6170-6178. PMID 7690419 DOI: 10.1128/Jvi.67.10.6170-6178.1993 |
0.554 |
|
| 1993 |
Yankaskas JR, Haizlip JE, Conrad M, Koval D, Lazarowski E, Paradiso AM, Rinehart CA, Sarkadi B, Schlegel R, Boucher RC. Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. The American Journal of Physiology. 264: C1219-30. PMID 7684560 DOI: 10.1152/Ajpcell.1993.264.5.C1219 |
0.499 |
|
| 1992 |
Goldstein DJ, Toyama R, Dhar R, Schlegel R. The BPV-1 E5 oncoprotein expressed in Schizosaccharomyces pombe exhibits normal biochemical properties and binds to the endogenous 16-kDa component of the vacuolar proton-ATPase. Virology. 190: 889-893. PMID 1387753 DOI: 10.1016/0042-6822(92)90932-F |
0.461 |
|
| 1992 |
Ghim SJ, Jenson AB, Schlegel R. HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology. 190: 548-52. PMID 1382345 DOI: 10.1016/0042-6822(92)91251-O |
0.449 |
|
| 1992 |
Goldstein DJ, Kulke R, Dimaio D, Schlegel R. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase. Journal of Virology. 66: 405-413. PMID 1370089 DOI: 10.1128/Jvi.66.1.405-413.1992 |
0.336 |
|
| 1992 |
Villa LL, Vieira KB, Pei XF, Schlegel R. Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18. Molecular Carcinogenesis. 6: 5-9. PMID 1323969 DOI: 10.1002/MC.2940060103 |
0.323 |
|
| 1992 |
Goldstein DJ, Andresson T, Sparkowski JJ, Schlegel R. The BPV‐1 E5 protein, the 16 kDa membrane pore‐forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. The Embo Journal. 11: 4851-4859. DOI: 10.1002/J.1460-2075.1992.Tb05591.X |
0.434 |
|
| 1991 |
Romanczuk H, Villa LL, Schlegel R, Howley PM. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. Journal of Virology. 65: 2739-44. PMID 1850048 DOI: 10.1128/Jvi.65.5.2739-2744.1991 |
0.552 |
|
| 1991 |
Villa LL, Schlegel R. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology. 181: 374-377. PMID 1847260 DOI: 10.1016/0042-6822(91)90507-8 |
0.502 |
|
| 1991 |
Finbow ME, Pitts JD, Goldstein DJ, Schlegel R, Findlay JB. The E5 oncoprotein target: a 16-kDa channel-forming protein with diverse functions. Molecular Carcinogenesis. 4: 441-4. PMID 1724370 DOI: 10.1002/Mc.2940040605 |
0.365 |
|
| 1991 |
Goldstein DJ, Fmbow ME, Andresson T, McLean P, Smith K, Bubb V, Schlegel R. Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases. Nature. 352: 347-349. PMID 1649407 DOI: 10.1038/352347A0 |
0.436 |
|
| 1990 |
Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Münger K, Howley PM, Moses HL. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 61: 777-85. PMID 2140528 DOI: 10.1016/0092-8674(90)90188-K |
0.367 |
|
| 1989 |
Burkhardt A, Willingham M, Gay C, Jeang KT, Schlegel R. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology. 170: 334-9. PMID 2541554 DOI: 10.1016/0042-6822(89)90391-7 |
0.422 |
|
| 1988 |
Bubb V, McCance DJ, Schlegel R. DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein Virology. 163: 243-246. PMID 2831662 DOI: 10.1016/0042-6822(88)90259-0 |
0.515 |
|
| 1988 |
Schlegel R, Phelps WC, Zhang Y, Barbosa M. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. The Embo Journal. 7: 3181-3187. DOI: 10.1002/J.1460-2075.1988.Tb03185.X |
0.479 |
|
| 1988 |
McBride AA, Schlegel R, Howley PM. The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. The Embo Journal. 7: 533-539. DOI: 10.1002/J.1460-2075.1988.Tb02842.X |
0.432 |
|
| 1987 |
Burkhardt A, DiMaio D, Schlegel R. Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein. The Embo Journal. 6: 2381-2385. DOI: 10.1002/J.1460-2075.1987.Tb02515.X |
0.385 |
|
| 1986 |
Schlegel R, Wade-Glass M, Rabson MS, Yang Y. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide Science. 233: 464-467. PMID 3014660 DOI: 10.1126/Science.3014660 |
0.476 |
|
| 1981 |
Banks-Schlegel SP, Schlegel R, Pinkus GS. Keratin protein domains within the human epidermis Experimental Cell Research. 136: 465-469. PMID 6171444 DOI: 10.1016/0014-4827(81)90028-8 |
0.323 |
|
| Show low-probability matches. |